“Food safety from the catastrophic complications of Guillain-Barre Syndrome caused by the Campylobacter jejuni food borne illness may become a real risk to the United States going forward with cuts of funding to the CDC, the USDA, and the FDA”…Greg Vigna, MD, JD
The Foodborne Diseases Active Surveillance Network (FoodNet) is a collaboration between the Centers for Disease Control and Prevention, U.S. Department of Agriculture, and the Food and Drug Administration (FDA), and 10 state health departments and conducts surveillance for Campylobacter, Cyclospora, Listeria, Salmonella, Shiga toxin-producing E.coli, Shigella, Vibrio, and Yersinia infections diagnosed by laboratory testing of samples from patients.
Read about the work in food surveillance by the FoodNet: https://www.cdc.gov/foodnet/about/index.html
Dr. Greg Vigna, MD, JD, national neurological injury attorney states, “Clearly employees of the CDC, USDA, and the FDA are tasked with the very important job that keeps us safe from preventable food borne illness, many of which have the potential to cause long-term disability. Government workers who are tasked with this important work should not be working remotely and are needed in the office.”
Dr. Vigna explains about the real risk of Campylobacter jejuni, “Guillain-Barre (GBS) is caused by immune mechanism where the body’s response to the bacterial infection cross-reacts with the myelinated motor and sensory nerves of the body leading to motor and sensory nerve damages and varying degrees of paralysis. I have managed dozens of patients with acute and chronic complications caused by Guillain-Barre following Campylobacter jejuni infection.”
What happened in Lima Peru in 2018 and 2019?
“The number of reported GBS cases increased from 59 in 2017 (incidence: 0.19/100,000) to 262 in 2018 (incidence: 0.81/100,000) and 1,120 in 2019 (incidence: 3.44/100,000)
Our study, describing a large cohort of patients and controls during the 2019 GBS outbreak in Lima, Peru, demonstrates that this outbreak was associated with C jejuni infection, a diarrheal bacterium that is the most common trigger of GBS worldwide”…Ana P. Ramos, M.D.
Read Dr. Ramos article “Guillain-Barre Syndrome Outbreak in Peru 2019 Associated with Campylobacter jejuni Infection”, published in Neurol Neuroimmunol Neuroinflamm 2021; 8:e 952: https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000000952
Greg Vigna, MD, JD, is a national malpractice attorney and mass tort product liability attorney. He is available for legal consultation for families and patients who have suffered decubitus ulcers because of poor nursing care at hospitals, nursing homes, or assisted living facilities. The Vigna Law Group along with Ben C. Martin, Esq., of the Martin Law Group, a Dallas Texas national pharmaceutical injury law firm, jointly prosecute cases on non-exclusive basis.
Greg Vigna, MD, JD
Vigna Law Group
8939 S. Sepulveda Blvd., Suite 102
Los Angeles, CA 90045
1-800-761-9206
Injury Care Solutions Group (ICSG) provides educational expert content that does not constitute medical advice, diagnosis, treatment, or legal advice or solicitation. ICSG is not a law firm or medical provider. Use of this website does not create a doctor–patient or attorney–client relationship. Do not send PHI through this Website. Attorney references (including references to Ben Martin Law Group) are for convenience only, and are not endorsements, guarantees or attorney advertising. Past results do not predict future outcomes. See Full Disclaimer and Privacy Policy. If deemed attorney advertising: Ben C. Martin, 4500 Maple Ave., Suite 400, Dallas, Texas 75219, licensed by the State Bar of Texas and Pennsylvania.